IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

IOL Chemicals & Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 23 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

IOL Chemicals & Pharmaceuticals Ltd experienced a notable intraday decline on 17 Jul 2026, touching a low of Rs 151.55, down 7.65% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate price pressures and subdued market sentiment despite a broadly positive Sensex session.

Surging to a fresh 52-week high of Rs 179.65 on 15 Jul 2026, IOL Chemicals & Pharmaceuticals Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market with an 87.96% gain over the past year against the Sensex’s decline of 6.08%.

Surging past its previous peak, IOL Chemicals & Pharmaceuticals Ltd touched a new 52-week high of Rs 178.75 on 14 Jul 2026, marking a remarkable 90.7% gain over the past year. This milestone reflects a powerful confluence of technical momentum and improving fundamentals that have propelled the stock well ahead of the broader market.

IOL Chemicals & Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 July 2026, providing investors with the most up-to-date view of its fundamentals, returns, and market performance.

IOL Chemicals & Pharmaceuticals Ltd (IOLCP) has emerged as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector, registering a remarkable surge in trading volume and price performance. The stock’s recent breakout to a new 52-week high, coupled with a significant increase in delivery volumes, points to strong accumulation and heightened investor interest amid a broadly subdued market environment.

With a remarkable surge to Rs 177.8 on 8 Jul 2026, IOL Chemicals & Pharmaceuticals Ltd has reached a new 52-week high, marking a 90.98% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price appreciation, even as the broader Sensex trades slightly lower.

The Sensex declined by 0.47% on 08 Jul 2026, while IOL Chemicals & Pharmaceuticals Ltd surged 7.67%, reaching an intraday high of Rs 176.55. This 5.34 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.

At Rs 173.35, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. IOL Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 20% on 06 Jul 2026, with buyers queuing and no sellers willing to part with shares.

IOL Chemicals & Pharmaceuticals Ltd (IOLCP) has emerged as one of the most actively traded stocks by value on 7 July 2026, registering a remarkable intraday gain of 18.49% and hitting a new 52-week high of ₹165.85. The stock’s robust performance is underpinned by strong institutional interest, significant order flow, and a recent upgrade in its Mojo Grade from Hold to Buy, signalling renewed investor confidence in this small-cap pharmaceutical player.

IOL Chemicals & Pharmaceuticals Ltd (IOLCP) witnessed a remarkable surge in trading volume and price on 7 July 2026, driven by strong accumulation signals and an upgrade in its Mojo Grade from Hold to Buy. The small-cap pharmaceutical company outperformed its sector and broader indices, hitting a new 52-week high amid heightened investor interest and volatility.

Surging past its previous peaks, IOL Chemicals & Pharmaceuticals Ltd touched a fresh 52-week high of Rs 166.65 on 7 Jul 2026, marking a remarkable 78.35% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market.

The Sensex edged up a modest 0.08% on 7 Jul 2026, while IOL Chemicals & Pharmaceuticals Ltd surged 9.83%, hitting a fresh 52-week high of Rs 156.1. This 8.09-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a broad market lift.

Surging past its previous peaks, IOL Chemicals & Pharmaceuticals Ltd reached a fresh 52-week high of Rs 148.65 on 2 Jul 2026, marking a significant milestone in its price momentum. This rally has been fuelled by a confluence of strong technical signals and sustained buying interest, propelling the stock well above its key moving averages and outperforming its sector peers.

Surging past Rs 147.5 on 1 Jul 2026, IOL Chemicals & Pharmaceuticals Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally reflects a powerful alignment of technical indicators and sustained momentum, propelling the stock well above its 52-week low of Rs 67.14 and delivering a remarkable 52.18% return over the past year.

IOL Chemicals & Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 July 2026, providing investors with the latest insights into its performance and outlook.